New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
10:00 EDTVTR, MGM, SPN, MFC, JOY, DOV, HEK, RDC, LUV, LSTR, FTI, PH, TKC, MKSI, KKR, CELGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Celgene (CELG) upgraded to Outperform from Sector Perform at RBC Capital... Celgene (CELG) upgraded to Overweight from Neutral at Piper Jaffray... Dover (DOV) upgraded to Overweight from Equal Weight at Morgan Stanley... FMC Technologies (FTI) upgraded to Buy from Neutral at Sterne Agee... Joy Global (JOY) upgraded to Overweight from Neutral at Piper Jaffray... KKR & Co. (KKR) upgraded to Buy from Neutral at Goldman... Landstar System (LSTR) upgraded to Outperform from Market Perform at Wells Fargo... MKS Instruments (MKSI) upgraded to Buy from Neutral at BofA/Merrill... Manulife Financial (MFC) upgraded to Buy from Neutral at BofA/Merrill... Southwest (LUV) upgraded to Buy from Hold at Deutsche Bank... Superior Energy (SPN) upgraded to Outperform from Sector Perform at RBC Capital... Turkcell (TKC) upgraded to Overweight from Neutral at HSBC... Rowan Companies (RDC) upgraded to Neutral from Underweight at JPMorgan... MGM Resorts (MGM) upgraded to Outperform from Neutral at Credit Suisse... Parker-Hannifin (PH)upgraded to Overweight from Neutral at JPMorgan... Ventas (VTR) upgraded to Buy from Hold at Jefferies... Heckmann (HEK) upgraded to Neutral from Sell at Ladenburg.
News For DOV;CELG;FTI;JOY;KKR;LSTR;MFC;MKSI;LUV;SPN;TKC;RDC;MGM;PH;HEK;VTR From The Last 14 Days
Check below for free stories on DOV;CELG;FTI;JOY;KKR;LSTR;MFC;MKSI;LUV;SPN;TKC;RDC;MGM;PH;HEK;VTR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 7, 2014
06:14 EDTLUVAirlines sector upgraded to Attractive from Neutral at Goldman
Goldman upgraded the Airlines sector to Attractive from Neutral based on a more bullish views on the cycle and improving demand. The analyst believes consensus estimates underestimate pricing, which will boost multiples. As part of the sector change, the firm initiated American Airlines (AAL) with a Buy rating and upgraded JetBlue (JBLU) to Neutral from Sell.
06:09 EDTRDCRowan downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley downgraded Rowan to Underweight from Equal Weight citing execution and jackup market concerns. Price target lowered to $33 from $42.
April 4, 2014
10:45 EDTCELGMylan rises despite Meda rejecting takeover offer
Mylan (MYL) shares are higher this morning following a Financial Times report of its desire to buy Swedish rival Meda. Subsequent to the story being published, Meda confirmed it had been in talks with Mylan but rejected the company's takeover offer. WHAT'S NEW: The Financial Times reported that Mylan was considering buying Meda, a Swedish drugmaker, in a deal that would create a $23B+ pharmaceuticals business. Mylan reportedly hired advisers to put a deal together for Meda, and though the value of a deal was not noted, sources said Mylan was likely to pay a "significant" premium to Meda's market value, which was $4.5B at the end of trading on Thursday. Mylan's market value currently stands at $18.5B. A combination of the drugmakers would create a company with annual revenues of around $9B, the FT said, noting that would be half the size of generic drug rival Teva (TEVA). WHAT'S NOTABLE: Meda's board of directors confirmed that it was contacted by Mylan regarding a proposal to merge the companies, but the board decided to reject the proposal. Meda said all discussions between the company and Mylan have been terminated "without further actions." ANALYST REACTION: Citigroup upgraded Mylan to Buy from Neutral and raised its price target on the stock to $61 from $52 this morning. The firm cited potential operational and tax benefits from an acquisition of Meda, stating that in addition to expanding Mylan's geographic presence, the deal would increase its presence in specialty, OTC and branded generics. OTHER NEWS: Mylan sued Celgene (CELG) to block that company's efforts to keep generic versions of Revlimid and Thalomid off the market, Reuters reported. PRICE ACTION: Mylan shares are up $2.98, or 5.98%, to $52.84 in mid-morning trading.
10:42 EDTSPNHigh option volume stocks: FENG GNK JRJC DLLR SPN
Subscribe for More Information
08:29 EDTLUVSouthwest valuation among cheapest in group, says Barclays
Barclays said Southwest's valuation is among the cheapest in the group and that its leverage to the domestic market is appealing. Shares are Overweight rated with a $28 price target, up from $26.
06:49 EDTCELGMylan sues Celgene for blocking Thalomid, Revlimid generics, Reuters says
Subscribe for More Information
April 3, 2014
10:00 EDTKKROn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:03 EDTTKCTurkcell volatility decreases on sharp rally and political stability
Subscribe for More Information
06:28 EDTCELGAtopic dermatitis could bring upside to Regeneron, Celgene, says Citigroup
Citigroup believes Regeneron's (REGN) dupilumab and Celgene's (CELG) Otezla for atopic dermatitis are being overlooked by investors and could provide upside for both names. Citi believes both drugs have good efficacy but adds that dupilumab is more advanced. The firm has a Buy rating on both stocks.
06:17 EDTKKRKKR initiated with an Outperform at Bernstein
Subscribe for More Information
April 2, 2014
12:33 EDTCELGOn The Fly: Midday Wrap
Subscribe for More Information
10:00 EDTDOVOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:29 EDTCELGAcceleron anemia programs get vote of confidence, says Piper Jaffray
Subscribe for More Information
09:18 EDTCELGOn The Fly: Pre-market Movers
Subscribe for More Information
09:00 EDTCELGCelgene to buy 1.1M shares of Acceleron Pharma for $47.15M
Subscribe for More Information
07:36 EDTLUVSouthwest coping with high costs, labor strife, WSJ says
Subscribe for More Information
07:30 EDTKKREnergy Future plan to nearly wipe out owners KKR to Goldman, Bloomberg says
KKR (KKR), TPG Capital and Goldman Sachs (GS) Capital Partners, the companies that acquired Energy Future Holdings, would nearly be wiped out in a reorganization plan being discussed, according to Bloomberg, citing three people with direct knowledge of the negotiations. Reference Link
07:30 EDTJOYShell looks to Chinese suppliers to lower shale costs, FT says
Subscribe for More Information
06:49 EDTDOVDover upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse upgraded Dover following the recent spin-off of Knowles and raised its price target to $93 from $81. The firm believes M&A could provide upside to earnings and that acceleration in the Energy segment deserves a premium multiple.
06:31 EDTKKRKKR looks for $2B for infrastructure fund, Bloomberg says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use